18F-FSPG PET/MRI Imaging of Cardiac Sarcoidosis or Inflammation
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2018
At a glance
- Drugs BAY 949392 (Primary)
- Indications Inflammation; Myocardial disorders; Sarcoidosis
- Focus Diagnostic use
- 31 Aug 2017 Status changed from not yet recruiting to recruiting.
- 09 May 2017 Planned initiation date changed from 1 Apr 2017 to 1 May 2017.
- 07 Apr 2017 New trial record